Sign In
Buy AGL
$86.75
-5.79 (-6.26%)
At Close: Jun 02, 2026
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced new research demonstrating the pro
PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Agilon Health, Inc. (NYSE:AGL) on behalf o
agilon health to Participate in Bernstein's 41st Annual Strategic Decisions Conference
04:04pm, Monday, 19'th May 2025
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the Be
agilon health, inc. (AGL) Q1 2025 Earnings Call Transcript
08:04pm, Tuesday, 06'th May 2025
agilon health, inc. (NYSE:AGL ) Q1 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steve Sell - Chief Executive Office
Agilon Health (AGL) Reports Break-Even Earnings for Q1
07:10pm, Tuesday, 06'th May 2025
Agilon Health (AGL) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago.
Bloodied But Unbowed, Agilon Health Can Profit From Improving Market Dynamics
02:39pm, Thursday, 10'th Apr 2025
agilon health's stock has surged over 165% YTD in 2025 despite a 77% decline since its 2021 IPO, driven by CMS rate hikes for 2026. The company faces challenges with significant operating losses and i
Agilon (AGL) Moves 26.1% Higher: Will This Strength Last?
09:55am, Wednesday, 09'th Apr 2025
Agilon (AGL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down
agilon health to Participate in BofA Securities 2025 Health Care Conference
04:15pm, Friday, 04'th Apr 2025
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the Bo
agilon health Sets Date to Report First Quarter 2025 Financial Results
04:05pm, Tuesday, 25'th Mar 2025
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
10:41am, Thursday, 20'th Mar 2025
Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
02:32pm, Tuesday, 18'th Mar 2025
J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month.
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
10:46am, Tuesday, 04'th Mar 2025
Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.
agilon health, inc. (AGL) Q4 2024 Earnings Call Transcript
12:25am, Wednesday, 26'th Feb 2025
agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executiv
Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say
06:30pm, Tuesday, 25'th Feb 2025
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates
06:10pm, Tuesday, 25'th Feb 2025
Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.41 per share a year ago.
